| Upcoming events on ASTRAZENECA PLC |
|
| 05/26/21 | | Erste CEE Innovation Conference |
| 05/26/21 | | CLSA Japan Forum |
| 06/07/21 | 10:00am | | ASCO Meeting |
| 06/09/21 | | Goldman Sachs Global Healthcare conference |
|
| Past events on ASTRAZENECA PLC |
|
| 05/12/21 | | Roadshow |
| 05/11/21 | 06:00am | | Annual General Meeting |
| 05/11/21 | | Bank of America Healthcare Conference |
| 05/07/21 | | Roadshow - Day - 4 |
|
| Upcoming sector events for ASTRAZENECA PLC |
|
|
| |
|
| Past sector events for ASTRAZENECA PLC |
|
|
|
|
|
| Annual results | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 (e) |
Sales
M $ |
Released
Forecast
Spread | 23 002
23 116
-0,49% | 22 465
22 117
1,6% | 22 090
22 157
-0,30% | 24 384
24 440
-0,23% | 26 617
26 378
0,91% |
31 079
|
Operating income
(EBITDA)
M $ |
Released
Forecast
Spread | 7 259
6 503
12% | 6 713
6 604
1,7% | 7 140
6 767
5,5% | 6 686
6 882
-2,8% | 8 311
8 087
2,8% |
9 787
|
Operating profit
(EBIT)
M $ |
Released
Forecast
Spread | 6 721
6 648
1,1% | 6 855
6 450
6,3% | 5 672
5 897
-3,8% | 6 436
6 631
-2,9% | 7 340
7 417
-1,0% |
8 919
|
Pre-Tax Profit
(EBT)
M $ |
Released
Forecast
Spread | 3 552
2 340
52% | 2 227
2 602
-14% | 1 993
2 712
-27% | 1 548
2 081
-26% | 3 916
4 387
-11% |
4 734
|
Net income
M $ |
Released
Forecast
Spread | 3 499
2 413
45% | 3 001
2 477
21% | 2 155
2 306
-6,6% | 1 335
1 895
-30% | 3 196
2 930
9,1% |
4 531
|
EPS
$ |
Released
Forecast
Spread | 2,76
1,92
44% | 2,37
1,90
25% | 1,70
1,79
-4,8% | 1,03
1,41
-27% | 2,44
2,50
-2,3% |
3,45
| | Announcement Date | 02/02/2017 | 02/02/2018 | 02/14/2019 | 02/14/2020 | 02/11/2021 | |
|
|
|
| Quarterly results | 2017 S1 | 2018 Q4 | 2019 Q1 | 2019 Q2 | 2019 Q3 | 2019 Q4 | 2020 Q1 | 2020 Q2 | 2020 Q3 | 2020 Q4 | 2021 Q1 | 2021 Q2 (e) | 2021 Q3 (e) | 2021 Q4 (e) |
Sales
M $ |
Released
Forecast
Spread | 10 456
10 440
0,15% | 6 417
6 332
1,3% | 5 491
5 398
1,7% | 5 823
5 571
4,5% | 6 406
6 056
5,8% | 6 664
6 749
-1,3% | 6 354
5 948
6,8% | 6 275
6 279
-0,07% | 6 578
6 642
-0,96% | 7 410
7 104
4,3% | 7 320
6 997
4,6% |
7 472
|
7 933
|
8 679
|
Operating income
(EBITDA)
M $ |
Released
Forecast
Spread |
| 2 739
3 280
-16% | 1 773
1 529
16% | 1 220
1 568
-22% | 1 473
1 909
-23% | 2 220
1 865
19% | 2 061
| 1 994
| 1 972
2 335
-16% | 2 284
1 737
31% | 2 692
2 904
-7,3% |
2 132
|
2 704
|
2 580
|
Operating profit
(EBIT)
M $ |
Released
Forecast
Spread | 3 215
2 650
21% | 2 192
2 422
-9,5% | 1 650
1 552
6,3% | 1 361
1 125
21% | 1 880
1 763
6,6% | 1 545
1 746
-11% | 1 854
1 688
9,9% | 1 792
1 679
6,7% | 1 795
1 811
-0,86% | 1 899
1 962
-3,2% | 2 524
2 545
-0,81% |
1 928
|
2 202
|
2 384
|
Pre-Tax Profit
(EBT)
M $ |
Released
Forecast
Spread |
| 730
1 516
-52% | 758
849
-11% | 141
281
-50% | 409
841
-51% | 240
486
-51% | 935
896
4,4% | 961
761
26% | 853
904
-5,6% | 1 167
1 033
13% | 1 608
1 591
1,1% |
|
|
|
Net income
M $ |
Released
Forecast
Spread |
| 1 034
1 212
-15% | 593
596
-0,55% | 130
268
-51% | 299
651
-54% | 313
771
-59% | 780
698
12% | 756
630
20% | 648
753
-14% | 1 012
881
15% | 1 561
1 347
16% |
670
|
964
|
1 417
|
EPS
$ |
Released
Forecast
Spread |
| 0,82
0,86
-4,5% | 0,47
0,49
-3,9% | 0,10
0,21
-53% | 0,23
0,49
-53% | 0,24
0,34
-30% | 0,59
0,50
19% | 0,58
0,48
21% | 0,49
0,56
-13% | 0,78
0,67
16% | 1,19
1,02
17% |
0,43
|
0,72
|
0,81
| | Announcement Date | 07/27/2017 | 02/14/2019 | 04/26/2019 | 07/25/2019 | 10/24/2019 | 02/14/2020 | 04/29/2020 | 07/30/2020 | 11/05/2020 | 02/11/2021 | 04/30/2021 | | | |
|
Financial data source
© 2021 S&P Global Market Intelligence
|
|
© 2021 Factset
|
|
|
|
AstraZeneca runs into 'meaningful' investor revolt over pay |
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
Previous period
